Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
- Harvard University
- National University of Singapore
- University of British Columbia
- Indiana University
- City of Hope
- Dana-Farber Cancer Institute (DFCI)
- Nanyang Technological University
- UNIVERSITY OF HELSINKI
- University of Michigan
- King's College London
- Max Planck Institute for Human Development, Berlin
- The Ohio State University
- UiT The Arctic University of Norway
- University of California
- University of Maryland, Baltimore
- University of Oxford
- Zintellect
- ADELAIDE UNIVERSITY
- BU Pulmonary
- Cori Institute of Molecular and Computational Metabolism
- Eisbach Bio GmbH
- Fundació Hospital Universitari Vall d'Hebron- Institut de recerca
- Humboldt-Universität zu Berlin
- Icelandic Heart Association
- Instituto de Investigação e Inovação em Saúde da Universidade do Porto (i3S)
- Lawrence Berkeley National Laboratory
- Margaret M Redfield
- Max Planck Institute of Biochemistry, Martinsried
- Mayo Clinic
- Monash University
- Northeastern University
- Research Center for Molecular Medicine (CeMM), ÖAW
- SciLifeLab
- Tampere University
- The University of Edinburgh;
- The University of Queensland
- Tokyo University of Science
- UT Health San Antonio Long School of Medicine
- University of Aberdeen;
- University of Birmingham
- University of Colorado
- University of Helsinki
- University of Leeds
- University of Michigan (U-M)
- University of Michigan - Ann Arbor
- University of New South Wales
- University of North Carolina at Charlotte
- University of Oklahoma Health Campus
- University of Oslo
- University of Otago
- University of Texas Rio Grande Valley
- Université de Strasbourg
- 42 more »
- « less
-
Field
-
tissue culture, animal models, high-parameter flow cytometry, spatial transcriptomics or proteomics, and cell gene engineering techniques is desired, but not required. This is an outstanding opportunity
-
damage responses, proteomics, genome editing, imaging, functional genomics and translational cancer research. The Project The post-holder will work within Professor D’Angiolella’s research group
-
opportunity to be part of a research effort aiming to dissect the cancer dark proteome and its therapeutic implications. The successful candidate will play a key role in advancing projects as part of the Cancer
-
Research Center for Molecular Medicine (CeMM), ÖAW | Graz 12 Bez Andritz, Steiermark | Austria | 2 months ago
, and interdisciplinary work at the interface of proteomics, structures and machine learning. Track 2: Metabolism, mitochondrial signalling and translational control (Graz) (Cori) This experimental
-
Research Scientist with expertise in B cell biology and biochemistry. Experience with proximity labeling experiments and proteomic analysis is preferred. This position is part of a dynamic research program
-
uniquely accessible human fetal tissue from the Scottish Advanced Fetal Research Study (SAFeR), advanced single-cell genomics, proteomics, spatial imaging and ex vivo human tissue models, the programme will
-
of infection or inflammation, innate immunity, and/or transcriptomic or proteomic approaches. The research environment offers access to a broad spectrum of state-of-the-art immunological techniques, including
-
in leading journals including NEJM AI, JAMA, and Circulation - the program fuses artificial intelligence, advanced cardiac imaging, multiomics (proteomics, metabolomics, and genomics), and
-
, protein structure modelling, AlphaFold/multimer-based analyses, statistics, data visualization, and interdisciplinary work at the interface of proteomics, structures and machine learning. Track 2
-
on neurodevelopmental disorders. The successful candidate will apply computational approaches to analyze high-throughput biological data, including genomics, transcriptomics, and proteomics datasets. You will collaborate